Skip to content
Peptide research

Humanin

Also known as HN Peptide
Category
Longevity & Anti-Aging
Administration routes
Injectable
Regulatory status
Not FDA-approved

What it is

A 24-amino-acid peptide encoded by mitochondrial DNA, marketed for neuroprotection, metabolic support, and longevity. The evidence is almost entirely cell and animal work; there are no controlled human trials and essentially no human safety data. Its anti-apoptotic, STAT3-driven mechanism raises an unresolved concern about promoting existing cancers. Not an approved drug in the US, and supply is unregulated research-grade material of uncertain purity.

Read Full record

Studied uses & evidence

Studied uses(8)

  • Neuroprotection against Alzheimer's disease pathology

    Medium

    Consistent animal and lab data show it shields neurons from Alzheimer's-related damage; no human trials yet.

  • Cytoprotection from apoptosis and oxidative stress

    Medium

    Its most replicated effect, protecting many cell types from death and oxidative stress; still preclinical.

  • Diabetes and insulin signaling modulation

    Medium

    Animal studies plus human data linking lower humanin to impaired fasting glucose; no treatment trials yet.

Evidence limits

Evidence Level
Preclinical only

All evidence for humanin comes from in vitro cell studies and animal models (C. elegans, mice, rats, primates). No completed human clinical trials exist as of March 2026. Observational human data shows reduced CSF humanin in Alzheimer's patients (n=3) and elevated circulating humanin in children of centenarians. Naked mole-rats maintain stable humanin levels across their lifespan, unlike mice which show ~40% decline over 18 months.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer

    Moderate

    Humanin is anti-apoptotic — helps cells resist programmed death. May protect cancer cells from apoptosis in some contexts.

General cautions

  • Pregnancy

    Absolute

    No human reproductive safety data. Anti-apoptotic effects during fetal development are unpredictable.

Risk summary(6)

Risks = level of concern: High · Moderate · Low · Theoretical

  • No controlled human clinical trials; all safety from preclinical

    High
  • Anti-apoptotic mechanism (Bax inhibition) may facilitate tumor progression in some cancers

    Moderate
  • Signals through STAT3, implicated in cancer progression

    Moderate
  • Transgenic humanin mice showed 46.5% decrease in litter size

    Low
  • Transgenic humanin mice showed 12% decrease in body length / 10.4% lower body weight

    Low
  • Injection site irritation (community reports)

    Low
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.